Cochlear Implants Market Ready to play long term Game with Set Goal

-
Cochlear implants are used to treat the hearing problems in deaf patients. These implant has replaced the old hearing aid devices. Many manufacturers are involved in improving the quality and design of the cochlear implants. During the last few years, there has been a significant increase in the demand for cochlear implants. According to the research carried out by DeafandHoH.com, LLC. in 2014, 360 million people worldwide were suffering from moderate to profound hearing loss. Additionally, according to the Centers for Disease Control and Prevention, by 2025, it is estimated that 900 million people across the globe are likely to suffer from hearing impairment of which around 90 million of these people may more likely from Europe. The global cochlear implants system market is majorly driven by increasing number of patients having hearing loss, rising geriatric population, acceptance of hearing implants by the patients with hearing disorders, and favorable reimbursement policies. According to the U.S. Census Bureau (2015), 8.5% of people across the globe i.e. 617 million were over age 65. During the last few years, people across the globe have adopted these devices, which have helped the growth of the market. According to the National Institute on Deafness and Other Communication Disorders, in 2013, approximately 324,200 registered devices have been implanted worldwide. Additionally, increasing healthcare expenditure and government support have fuelled the market growth. However, the cost of impacts can be more than USD 100,000 which are not affordable to the middle-class population, thus, the high cost of the implants may slow the growth of the market.
The market for Cochlear Implants Market is expected to grow at the CAGR of 9.86% during the forecast period and is estimated to reach USD 3,203.8 million by 2023.
Segments
The Global Cochlear Implants Market has been segmented on the basis of products, types and end users.
On the basis of the products, the global cochlear implants market is segmented into the cochlear implant system, and accessories & upgrades.
On the basis of the types, the market is segmented into the unilateral implant and bilateral implant.
On the basis of the end users, the market is segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others. 
Key players in the global cochlear implants market:
Some of the major players in this market are Advanced Bionics AG (Switzerland), MED-El (Austria), Cochlear Ltd (Australia), GAES MÉDICA (Spain), William Demant Holding Group (Denmark), Widex (Denmark), and Microson S.A. (Spain).
Get Sample Copy at https://www.marketresearchfuture.com/sample_request/5256 .
Key Findings:
  • The global cochlear implants market is expected to grow at a CAGR of 9.86% during the period 2017-2023. Increasing prevalence of the ear infection, increasing geriatric population, and technological advances are some of the major factors responsible for market growth
  • The cochlear implant system type of the products holds the major share of the market
  • MED-El, Cochlear Ltd, Advanced Bionics AG, GAES MÉDICA, and William Demant Holding Group are some of the prominent market players in the global cochlear implants market
Regional analysis
The Americas accounted for the major share of the market owing to the presence of huge patients suffering from hearing loss, well-developed technology, high healthcare expenditure, and government support for the research & development. According to the National Institute on Deafness and Other Communication Disorders, in 2015, over 15% of American adults i.e. 37.5 million aged 18 and over were suffering from hearing problems. Additionally, the presence of a number of leading players and favorable reimbursement policies have fuelled the growth of the market. 
Europe accounted for the second largest cochlear implants market, which is followed by the Asia Pacific. Increasing number of patients suffering from hearing problems, ear infection and other diseases have boosted the growth of the market. The high healthcare expenditure in this region is likely to provide a push to the growth of the market. Furthermore, increasing government support and funding for the development and treatment improvement have fuelled the growth of the market.
The Asia Pacific is the fastest growing cochlear implants market across the globe. Increasing need for better devices, rapidly improving technology, and the presence of huge patient pool drives the growth of this market in Asia Pacific region. 
The Middle East & Africa holds the least share of the market owing to the presence of poor and slow developing countries, especially, in the African region. Furthermore, increasing aging population and undeveloped market of the medical devices are the major drivers in this region. 
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312


Comments

Post a Comment

Popular posts from this blog

Actinic Keratosis Treatment Market Share, Demand, New Opportunities and Foresight to 2024

-
Market Research Future has added a report titled “Actinic Keratosis Treatment Market Research Report- Forecast to 2024” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe. Report Overview: Rise in the diagnosis efficiency of various types of cancers especially those related to the skin such as actinic keratosis are growing promptly. The treatment of actinic keratosis is gaining increasing prominence due to an extensive range of factors that are contributing to the expansion of the market. Actinic keratosis is a commonly diagnosed skin disorder that can potentially progress to non-melanoma skin cancers, this particular characteristic of the disease has contributed to the demand for its treatment significantly. A typical patient example with actinic keratosis is usually observed as having fair and sun-sensitive skin. Get Premium Copy @  https://www.marketr
Read more

Wearable Medical Device Market Poised for Steady Growth in the Future 2027

-
The Global  Wearable Medical Device   Market  Research   Report provides detailed analysis of the key regional market status of the Healthcare Industry. The  Wearable Medical Device Market  is expected to reach USD 4 billion in the forecasted period. The market is expected to grow at a CAGR of 26.78%. This growth in the market can be due to various factors such as increasing focus on fitness among individuals and awareness about healthy lifestyle. Furthermore signi8ficant growth in the home healthcare is expected to push up the demand for this segment. Top key players in the  wearable Medical Device market  are:  Fitbit Inc., Garmin, Vital Connect, Omron Corp., Sotera Wireless, Jawbone, Pebble Technology Corp., Basis Science Inc., Withings, Intelesens Ltd., Covidien Plc, LifeWatch AG, Polar Electro, Philips Electronics, and Everist Genomics. Get Sample copy at  https://www.marketresearchfuture.com/sample_request/899  . Segments The  Wearable Medical Device Market  can be
Read more

Peripheral Artery Disease Market Will Watch a Sensational Development by 2023: Industry Assertions by MRFR

-
MRFR is the Leading Brand in The Research Company who Recently Published Peripheral Artery Disease Market Research Reports which includes Study of growth, Regional Analysis, Top Industry Players Formation, Major Drivers, Upcoming Trends and Forecast to 2023. Get Sample Copy @   https://www.marketresearchfuture.com/sample_request/1540 Industry Leading Players: Boston Scientific Corporation, KONINKLIJKE PHILIPS N.V, Abbott, Medtronic, B. Braun Melsungen AG, TERUMO CORPORATION, Becton, Dickinson and Company (BD), Sanofi S.A., Johnson & Johnson Services, Inc., AstraZeneca Plc., Angioscore, Inc., Bristol-Myers Squibb Company, Betagenon AB, Proteon Therapeutics, Inc., Merck & Co., Inc., Bayer HealthCare Pharmaceuticals, Symic Bio, Inc., CardioVascular BioTherapeutics, Inc., AnGes, Inc., TheraVasc Inc., Smith & Nephew plc, Stryker Corporation, Cook Medical, Cordis, Aspen Surgical Products, Inc., Alcon Laboratories, Inc., Zimmer Biomet Holdings, Inc., and others are some of
Read more